Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 8 hours ago
Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities
about 8 hours ago
Global contract research organization Icon has announced the opening of a new...
With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
about 11 hours ago
Three weeks into taking on the role of Lexicon Pharmaceuticals CEO back...
Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
about 11 hours ago
Humacyte was riding high in December 2024 when it secured an FDA...
Fosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset
about 12 hours ago
Fosun Pharma has paid $60 million for an option on AriBio’s late-phase...
Valneva to lay off up to 15% of workforce in face of ‘adverse trend‘ in travel vaccines
about 13 hours ago
Valneva is planning to shrink its headcount by up to 15% as...
Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit
about 13 hours ago
Medtronic will shutter its Santa Rosa facility that produces coronary stents and...
Takeda 0 for 4 against nausea and vomiting after axing another asset
about 16 hours ago
Takeda has ended development of its nausea and vomiting drug candidate for...
AstraZeneca pens agentic AI licensing deal with Owkin
about 20 hours ago
AstraZeneca is the latest Big Pharma company looking to tap into agentic...
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
1 day ago
Kyverna Therapeutics has officially started a rolling submission to the FDA for...
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
1 day ago
Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief...
Charles River debuts AI diagnostic tool to cut down pathology timelines
1 day ago
Charles River is rolling out an artificial intelligence-backed digital pathology platform with...
Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
1 day ago
If any proof was needed that big money is still available for...